Researchers have discovered how a cell surface protein called Aplp1 can play a role in spreading material responsible for ...

Alpha-synuclein was first linked to Parkinson's disease in 1997, when a genetic mutation was discovered in some patients. Subsequent investigations showed that alpha-synuclein is abundant in Lewy ...

A major research breakthrough on Parkinson's disease revealed that an already FDA-approved cancer drug could help stem the spread of brain proteins believed to be responsible for Parkinson's ...

The PADOVA trial of alpha-synuclein-targeting antibody prasinezumab wasn't able to show a statistically significant extension in the time to motor progression in patients with early-stage ...

The assay for a particular abnormal form of the protein alpha-synuclein – known as αSyn-SAA – could also be used to diagnose people with Parkinson’s more quickly, help identify the best ...

Parkinson’s disease is a brain disorder that affects movement, making everyday tasks difficult for nearly one million people ...

The major mechanism behind Parkinson’s disease is well established – a toxic form of a protein called alpha-synuclein that accumulates inside neurons in clusters, eventually driving cell death ...

He injected them with the reactive alpha-synuclein fragment and monitored their weight and gastrointestinal (GI) transit times by orally administering a nonabsorbable red dye with food and measuring ...

Inhibikase Therapeutics announced disappointing results from a Phase 2 trial for its Parkinson’s disease drug, risvodetinib, ...